• 97
  • Comment
  • Favorite

Pfizer raises estimates for 2021 sales of COVID-19 vaccine to $33.5 bln

Reuters2021-07-28

July 28 (Reuters) - Pfizer Inc on Wednesday raised its forecast for sales of the COVID-19 vaccine that it developed with Germany's BioNTech by 28.8% to $33.5 billion, as countries scramble to secure supply of the shots.

The company said the raised sales forecast of the vaccine is based on signed deals for 2.1 billion doses this year.

The drugmaker's previous forecast in May of $26 billion was based on deals signed for 1.6 billion doses. Wall Street analysts were broadly in line with that forecast at $28.51 billion, according to nine analysts polled by Refinitiv.

Since then, Pfizer has said it expects to produce as much as 3 billion doses this year.

Expenses and profit from the vaccine are split 50-50 between Pfizer and BioNTech.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Superstar_L
    ·2021-07-30
    Good 
    Reply
    Report
  • Kencom
    ·2021-07-30
    The higher the demand, profitability will follow suit.
    Reply
    Report
  • OPP
    ·2021-07-29
    More and more to come with increasing confidence in it’s vaccine 
    Reply
    Report
  • TrillionDM
    ·2021-07-29
    Really
    Reply
    Report
  • Jazling
    ·2021-07-28
    Wow
    Reply
    Report
    Fold Replies
    • Jazling
      Ok
      2021-07-28
      Reply
      Report
  • DreamerAnt
    ·2021-07-28
    good sharing
    Reply
    Report
  • phily
    ·2021-07-28
    Up up n away
    Reply
    Report
  • Stekii
    ·2021-07-28
    Only medical firms manufacture covid vaccine in luck
    Reply
    Report
  • Stekii
    ·2021-07-28
    Must have made a lot of profit
    Reply
    Report
    Fold Replies
    • sunshine138
      Look at BNTX the shares have wings compare to PFE
      2021-07-28
      Reply
      Report
  • hahahayesyes
    ·2021-07-28
    like pls
    Reply
    Report
  • Yappie830
    ·2021-07-28
    Minimal impact on stock price even though they are one of the key producer of the Covid-19 vaccine… why ah??
    Reply
    Report
    Fold Replies
    • Darius88
      I think coz they lost their place in S&P 500, They didnt make alot of money past few years and gIve it away in diviDends and also no Blockbuster dRUg in their pipeline.
      2021-07-28
      Reply
      Report
  • GuSen
    ·2021-07-28
    What a great bio-hard-on result!
    Reply
    Report
  • Jack_Chen_qy
    ·2021-07-28
    Nice
    Reply
    Report
  • Noted
    Reply
    Report
  • Wilson_wtc
    ·2021-07-28
    Ok
    Reply
    Report
  • babykangar00
    ·2021-07-28
    Ok
    Reply
    Report
  • HollandJun
    ·2021-07-28
    Gogogo
    Reply
    Report
  • ChickenWeng
    ·2021-07-28
    Team Pfizer!
    Reply
    Report
  • Shadowrider
    ·2021-07-28
    Wow
    Reply
    Report
    Fold Replies
    • vcvcbc
      H
      2021-07-28
      Reply
      Report
    • JasonTan00
      nice
      2021-07-28
      Reply
      Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial